Cholesterol Ratios: Why One Number Is Not the Answer
A lipid result comes back with five numbers on it, one of them flagged, and the conversation that follows usually concerns whichever number is highlighted. That is a poor way to read the sheet, because the individual figures mean far less on their own than they do in relation to each other.
What follows is what the ratios actually tell you, why the familiar division into good and bad cholesterol turns out to be misleading in a specific and important way, and two tests that predict risk well and are almost never ordered.
📊 Why a ratio outperforms a single figure. Total cholesterol lumps together particles that deposit fat into artery walls and particles that carry it away. Two people with identical totals can be at very different risk depending on the proportions.
Divide one by the other and the composition becomes visible. That is all an atherogenic index is — a way of expressing the balance between the particles that cause harm and those that do not, in a single figure that predicts events better than either component alone.
🧮 The ratios worth knowing
| Measure | What it tells you |
|---|---|
| Total cholesterol divided by HDL | The classic ratio. Predicts cardiovascular events better than total cholesterol alone, and is simple to calculate from any standard result |
| Triglycerides divided by HDL | The most informative of the ratios, and the one most often ignored. Discussed below |
| Non-HDL cholesterol | Total minus HDL. Captures every particle that can lodge in an artery wall, in one figure, and needs no fasting. A better target than LDL alone |
| ApoB | Counts the actual number of harmful particles rather than the cholesterol inside them. Increasingly the preferred measure where available |
The last two deserve emphasis. LDL cholesterol measures how much cholesterol is being carried; it does not measure how many particles are carrying it. Two people with the same LDL can have very different particle numbers, and it is the number of particles that determines how many can penetrate an artery wall. Where LDL looks acceptable but triglycerides are high, LDL is understating the risk, and non-HDL cholesterol or ApoB will show it.
🍬 The ratio that reveals something else entirely
Dividing triglycerides by HDL produces a number that is useful well beyond the heart, because it is a good marker of insulin resistance.
The connection is mechanical. When cells respond poorly to insulin, the liver produces more triglyceride-rich particles, HDL falls, and LDL particles become smaller and denser — and small dense particles penetrate artery walls more readily than large buoyant ones. So a raised ratio simultaneously signals a metabolic problem and a more dangerous particle profile.
Practically, a person with high triglycerides and low HDL is being told something about how their body handles sugar, several years before a glucose test becomes abnormal. That is worth acting on with the metabolic tools described in the article on exercise and insulin sensitivity, rather than treating it as a cholesterol problem alone.
It also responds well. Triglycerides fall substantially with weight reduction, reduced alcohol, less refined carbohydrate and more activity — far more responsively than LDL does.
⚠️ The problem with good cholesterol
🧪 Low HDL predicts risk reliably. Raising it with drugs does not reduce risk. Those two statements sound contradictory and both are true, and the gap between them changes how the number should be read.
Several drug classes were developed specifically to raise HDL. One raised it substantially and increased deaths. Two others raised it and produced no benefit at all. Large trials of niacin, which raises HDL effectively, found no reduction in cardiovascular events when added to a statin, along with increased rates of diabetes, infection and bleeding. Genetic studies point the same way: people born with HDL-raising variants do not have fewer heart attacks.
The conclusion the field reached is that HDL is a marker rather than a lever — a reading that reflects underlying metabolic health rather than something that causes protection. Low HDL is a signal worth heeding. It is not a target to be raised with medication.
What raises it usefully is what improves the underlying state: exercise, weight reduction, stopping smoking. Those work on the whole picture rather than on one number.
🧬 The test nobody orders
There is a particle called lipoprotein(a), and it deserves far more attention than it gets.
Levels are almost entirely determined by genetics. They do not move meaningfully with diet, exercise or weight, and statins do not lower them. Roughly one person in five carries a raised level, and in those people it is an independent risk factor for heart attack, stroke and narrowing of the aortic valve — independent meaning it adds risk on top of whatever the rest of the panel shows.
Because it is genetically fixed, it needs measuring only once in a lifetime. That single test explains a proportion of the cases that puzzle everybody: the person with a heart attack at fifty and an unremarkable cholesterol panel, or the family with early heart disease and no obvious explanation.
Knowing the result does not currently produce a specific treatment, since drugs targeting it are still in trials. What it does is change how aggressively everything else is managed, and it flags the family for testing. It is worth asking for by name, particularly with any family history of early cardiovascular disease.
👪 When the number is very high from birth
An inherited condition causing markedly raised LDL from childhood affects roughly one person in two hundred and fifty, which makes it one of the commoner genetic conditions there is. The great majority of those affected have not been diagnosed.
It matters because the exposure starts at birth rather than in middle age, so arteries accumulate decades of extra damage before anyone measures anything. Untreated, it produces heart disease considerably earlier than usual. Treated from early adulthood, life expectancy is close to normal.
Features that should prompt the question: an LDL that is very high rather than moderately raised, a family history of heart attack or stroke before the age of about sixty, thickening of the Achilles tendons or lumps over the knuckle tendons, or a pale ring around the cornea in someone under forty-five.
If it is identified, the whole family needs testing — each first-degree relative has a one-in-two chance of carrying it, and finding them is the single most productive thing that follows the diagnosis.
📋 A number is not a decision
Whatever the ratio shows, treatment is not decided by any figure in isolation. It is decided by overall risk, which combines age, sex, blood pressure, smoking, diabetes, family history and kidney function alongside the lipids. The same cholesterol result justifies treatment in one person and not in another.
Two practical points about testing itself. Fasting is no longer required for a routine lipid panel in most guidance, which removes a common obstacle. And a single abnormal result is usually repeated before acting, since values fluctuate with illness, recent alcohol and recent meals.
It is also worth remembering what the whole exercise is for. The article on erectile difficulty makes the point that the narrowest arteries report artery damage first — these numbers are one way of estimating the same process before it announces itself.
💊 Treatment, and the muscle question
Statins lower LDL and reduce heart attacks and strokes in proportion to how much they lower it. That relationship is among the more consistent findings in cardiovascular medicine.
The recurring obstacle is muscle symptoms, and the picture here is genuinely interesting. Trials in which people alternated between statin and identical dummy tablets, without knowing which they were taking, found that the great majority of the symptom burden occurred equally during the dummy months.
That finding is frequently reported as proving the symptoms are imaginary, which is both unkind and wrong. The aches are real and are really felt. What the trials show is that in most cases they are not being caused by the drug — and that matters, because it means the majority of people who stopped can successfully take a statin again, often after a switch or a dose change. Genuine statin muscle injury exists and is uncommon; severe muscle breakdown is rare.
Anyone with unexplained muscle pain on a statin should have it assessed rather than simply stopping, and anyone who stopped years ago because of aches is worth rechallenging.
| Option | Notes |
|---|---|
| Statins | First-line. Differ in potency and in how they are metabolised, so intolerance to one does not predict intolerance to another |
| Ezetimibe | Blocks cholesterol absorption from the gut. Adds a useful further reduction, and is well tolerated as an alternative where a statin cannot be used |
| Fibrates | Mainly for very high triglycerides, where the immediate concern is pancreatitis rather than the arteries |
| Bile acid binders | Effective and awkward to take, and they interfere with the absorption of other medicines, which need separating in time |
| Niacin | Raises HDL and does not reduce events. Superseded, for the reasons set out above |
One interaction worth knowing: grapefruit raises blood levels of some statins substantially — simvastatin, atorvastatin and lovastatin — while leaving others unaffected. It is a real interaction and it applies to some drugs in the class and not others, so it is worth checking against your specific tablet rather than assuming either way. The article on food and medicine interactions covers why this happens.
🥗 What actually moves the numbers
Different measures respond to different things, which is worth knowing before making changes that will not show up.
Triglycerides are the most responsive — they fall substantially with weight reduction, less alcohol, less refined carbohydrate and more activity. Changes here show within weeks.
LDL responds mainly to the type of fat eaten, specifically replacing saturated fat with unsaturated, and to soluble fibre from oats, beans, pulses and fruit. Dietary cholesterol itself, which dominated advice for decades, has a smaller effect than assumed in most people.
HDL responds to exercise and stopping smoking, modestly, and as discussed above the value of that is in what it reflects rather than in the number itself.
Lipoprotein(a) responds to nothing currently available, which is why it is measured once and then used to inform how firmly everything else is treated.
🩺 When to seek help
- Chest pain on exertion, or breathlessness that is new — assessment rather than another blood test
- A very high LDL result, particularly with a family history of early heart disease — ask about the inherited condition
- Heart attack or stroke in a parent or sibling before sixty — you should be tested, and ask about lipoprotein(a)
- Thickened Achilles tendons, lumps over knuckle tendons, or a corneal ring under forty-five
- Very high triglycerides — the immediate risk is inflammation of the pancreas, which is a different and more urgent problem
- Muscle pain on a statin — assessment rather than stopping, and rechallenge is usually possible
- Severe muscle pain with dark urine — urgent
- Previously stopped a statin because of aches — worth revisiting, since most people tolerate a different one
- A raised triglyceride to HDL ratio — ask about blood sugar as well as cholesterol
Treatment is stocked in the cholesterol category, including Lipitor (atorvastatin) and Crestor (rosuvastatin), which differ in how they are metabolised — relevant to the grapefruit interaction and to why intolerance to one does not predict intolerance to another. Zetia (ezetimibe) adds a further reduction or substitutes where a statin cannot be used, and Tricor (fenofibrate) is used mainly where triglycerides are very high. The choice and the target depend on overall cardiovascular risk rather than on any single number.
❓ Frequently asked questions
Why use a ratio rather than my cholesterol number?
Because total cholesterol combines particles that deposit fat into artery walls with particles that carry it away, so two people with identical totals can be at very different risk. Dividing one by the other makes the composition visible and predicts events better than either component alone. It can be calculated from any standard result without extra testing.
Which ratio is the most useful?
Triglycerides divided by HDL, and it is the one most often ignored. It signals insulin resistance as well as cardiovascular risk, because poor insulin response makes the liver produce more triglyceride-rich particles, lowers HDL, and makes LDL particles smaller and denser — and smaller particles penetrate artery walls more readily. It often flags a metabolic problem years before a glucose test becomes abnormal.
Should I try to raise my good cholesterol?
Not with medication. Low HDL predicts risk reliably, but drugs that raise it have failed repeatedly — one increased deaths, two produced no benefit, and niacin trials found no reduction in events plus more diabetes, infection and bleeding. Genetic studies agree. HDL appears to be a marker of underlying metabolic health rather than a lever. Exercise, weight reduction and stopping smoking raise it usefully because they improve the whole picture.
What is non-HDL cholesterol and why is it better?
Total cholesterol minus HDL, which captures every particle capable of lodging in an artery wall in a single figure and requires no fasting. It matters most when triglycerides are high, because in that situation LDL alone understates the risk. ApoB goes further by counting the actual number of harmful particles rather than the cholesterol inside them, and is increasingly preferred where available.
What is lipoprotein(a) and should I be tested?
A particle whose level is almost entirely genetic — unaffected by diet, exercise, weight or statins. About one person in five has a raised level, where it independently increases risk of heart attack, stroke and aortic valve narrowing. Because it is fixed, it needs measuring only once in a lifetime. It explains a proportion of early heart attacks in people with otherwise unremarkable panels, and is worth asking for by name with any family history.
When is very high cholesterol inherited?
An inherited condition affecting roughly one in two hundred and fifty people causes markedly raised LDL from birth, and most cases are undiagnosed. Suspect it with an LDL that is very high rather than moderately raised, heart attack or stroke in the family before about sixty, thickened Achilles tendons, lumps over knuckle tendons, or a corneal ring under forty-five. Treated from early adulthood, life expectancy is close to normal — and every first-degree relative should be tested.
Do I need to fast for a cholesterol test?
Usually not. Most current guidance accepts non-fasting samples for routine testing, which removes a common obstacle to getting tested at all. A single abnormal result is generally repeated before acting on it, since values fluctuate with recent illness, alcohol and meals.
Are statin muscle aches real?
The aches are real and really felt. What trials show is that in most cases the statin is not causing them — in studies where people alternated between statin and identical dummy tablets without knowing which, the great majority of symptoms occurred equally during the dummy months. That matters practically: most people who stopped can take a statin again, often after a switch or dose change. Genuine statin muscle injury exists and is uncommon.
Does grapefruit matter with my statin?
With some and not others. Grapefruit substantially raises blood levels of simvastatin, atorvastatin and lovastatin by blocking the enzyme that clears them, while leaving several others unaffected. It is a genuine interaction rather than a myth, and because it applies selectively it is worth checking against your specific tablet rather than assuming it does or does not apply.
Which numbers respond fastest to lifestyle change?
Triglycerides by a wide margin — they fall substantially with weight reduction, less alcohol, less refined carbohydrate and more activity, and changes show within weeks. LDL responds mainly to replacing saturated fat with unsaturated and to soluble fibre from oats, beans and pulses. HDL moves modestly with exercise and stopping smoking. Lipoprotein(a) responds to nothing currently available.
📑 Sources and editorial
- Literature on lipid ratios and their predictive performance relative to single lipid measures
- Evidence on the triglyceride to HDL ratio as a marker of insulin resistance and small dense LDL predominance
- Guideline positions on non-HDL cholesterol and apolipoprotein B as treatment targets, including discordance with LDL cholesterol
- Outcome trials of HDL-raising interventions, including CETP inhibitors and niacin added to statin therapy
- Mendelian randomisation studies of HDL-raising genetic variants and cardiovascular risk
- Literature on lipoprotein(a) heritability, prevalence of elevation and independent risk association
- Guidance on familial hypercholesterolaemia prevalence, diagnostic features and cascade screening
- Guidance on non-fasting lipid measurement
- Randomised n-of-1 rechallenge trials of statin-associated muscle symptoms
- Evidence on ezetimibe added to statin therapy, and on fibrate use in severe hypertriglyceridaemia
- Pharmacological literature on grapefruit interaction by individual statin
- Related reading: arteries and early warning signs, exercise and insulin sensitivity, blood pressure
- Related products: cholesterol category
- RXshop Editorial Team — reviewed by Robert Hayes, MD, Cardiology
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.